Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study.
López-Gálvez R, Rivera-Caravaca JM, Anguita Sánchez M, Sanmartín Fernández M, Rafols C, Pérez-Cabeza AI, Barón Esquivias G, Lekuona Goya I, Vázquez Rodríguez JM, Cosín Sales J, Arribas Ynsaurriaga F, Barrios V, Freixa-Pamias R, Marín F.
López-Gálvez R, et al. Among authors: baron esquivias g.
Eur J Clin Invest. 2022 Sep;52(9):e13788. doi: 10.1111/eci.13788. Epub 2022 Apr 14.
Eur J Clin Invest. 2022.
PMID: 35395094